| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |